No Serological Evidence of Influenza A H1N1pdm09 Virus Infection as a Contributing Factor in Childhood Narcolepsy after Pandemrix Vaccination Campaign in Finland

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Melén, Krister ^a   Partinen, Markku ^b   Tynell, Janne ^a   Sillanpää, Maarit ^a   Himanen, Sari Leena ^c   Saarenpää Heikkilä, Outi ^d   Hublin, Christer ^e   Olsen, Päivi ^f   Ilonen, Jorma ^g,h   Nohynek, Hanna ^a   Syrjänen, Ritva ^a   Kilpi, Terhi ^a   Vuorela, Arja ^a   Kirjavainen, Turkka ⁱ   Vaarala, Outi ^a   Julkunen, Ilkka ^a,h  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

^e FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^f OULU UNIVERSITY HOSPITAL   (Finland)

^g UNIVERSITY OF EASTERN FINLAND   (Finland)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NONSTRUCTURAL PROTEIN 1;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DISEASE ASSOCIATION; FINLAND; HUMAN; INCIDENCE; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; NARCOLEPSY; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEROLOGY; UNINDEXED SEQUENCE; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADOLESCENT; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FINLAND; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NARCOLEPSY; PANDEMICS; SEROLOGIC TESTS; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84881345115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068402     Document Type: Article

References (38)

1. The International Classification of Sleep Disorders (2005): Diagnostic and Coding Manual. Westchester: American Academy of Sleep Medicine.
2. Lin L, Faraco J, Li R, Kadotani H, Rogers W, et al. (1999) The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98: 365-376.
3. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, et al. (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98: 437-451.
4. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E, (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355: 39-40.
5. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, et al. (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27: 469-474.
6. Silber MH, Krahn LE, Olson EJ, Pankratz VS, (2002) The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25: 197-202.
7. Longstreth WT Jr, Koepsell TD, Ton TG, Hendrickson AF, van Belle G, (2007) The epidemiology of narcolepsy. Sleep 30: 13-26.
8. Dauvilliers Y, Montplaisir J, Molinari N, Carlander B, Ondze B, et al. (2001) Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57: 2029-2033.
9. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, et al. (2001) Complex HLA-DR and-DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 68: 686-699.
10. Hong SC, Lin L, Jeong JH, Shin YK, Han JH, et al. (2006) A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness. Sleep 29: 1429-1438.
11. Han F, Lin L, Warby SC, Faraco J, Li J, et al. (2011) Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 70: 410-417.
12. Aran A, Lin L, Nevsimalova S, Plazzi G, Hong SC, et al. (2009) Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32: 979-983.
13. Longstreth WT Jr, Ton TG, Koepsell TD, (2009) Narcolepsy and streptococcal infections. Sleep 32: 1548.
14. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, Hublin C, Linna M, et al. (2012) Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 7: e33723.
15. Nohynek H, Jokinen J, Partinen M, Vaarala O, Kirjavainen T, et al. (2012) AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 7: e33536.
16. Szakacs A, Darin N, Hallbook T, (2013) Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 80: 1315-1321.
17. Miller E, Andrews N, Stellitano L, Stowe J, Winstone AM, et al. (2013) Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346: f794.
18. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, et al. (2003) HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 62: 162-169.
19. Ronkko E, Ikonen N, Kontio M, Haanpaa M, Kallio-Kokko H, et al. (2011) Validation and diagnostic application of NS and HA gene-specific real-time reverse transcription-PCR assays for detection of 2009 pandemic influenza A (H1N1) viruses in clinical specimens. J Clin Microbiol 49: 2009-2011.
20. Ikonen N, Haanpaa M, Ronkko E, Lyytikainen O, Kuusi M, et al. (2010) Genetic diversity of the 2009 pandemic influenza A(H1N1) viruses in Finland. PLoS One 5: e13329.
21. Laemmli UK, (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
22. Melen K, Kinnunen L, Fagerlund R, Ikonen N, Twu KY, et al. (2007) Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol 81: 5995-6006.
23. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Sprong Harbor, N.Y.: Cold Spring Harbor Laboratory.
24. Kendal AP, Pereira MS, Skehel JJ (1982) Concepts and procedures for laboratory-based influenza surveillance. Centers for Disease Control and Prevention and Pan-American Health Organization, Atlanta.
25. World Health Organization Gisn (2011) Manual for the laboratory diagnosis and virological surveillance of influenza. Geneva, Switzerland: World Health Organization. 140.
26. Tamura K, Dudley J, Nei M, Kumar S, (2007) MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24: 1596-1599.
27. Saitou N, Nei M, (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406-425.
28. Tamura K, Nei M, Kumar S, (2004) Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci U S A 101: 11030-11035.
29. Hillis DM, Bull JJ, (1993) An empirical test of bootstrapping as a method for assessing confidence in phylogenetic analysis. Syst Biol 42: 182-192.
30. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310: 77-80.
31. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-2615.
32. Vainio A, Fagerlund R, Melen K, Lehtinen MJ, Julkunen I, et al. (2006) Serum antibodies to putative proteinase maturation protein A in children with acute otitis media. Vaccine 24: 1792-1799.
33. Sillanpaa M, Melen K, Porkka P, Fagerlund R, Nevalainen K, et al. (2009) Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection. Virol J 6: 84.
34. Eurosurveillance editorial team (2011) Swedish Medical Products Agency publishes report from a case inventory study on Pandemrix vaccination and development of narcolepsy with cataplexy. Euro Surveill 16.
35. Han F, Lin L, Li J, Dong XS, Mignot E (2012) Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol. doi: 10.1002/ana.23799. [Epub ahead of print].
36. Agence francaise de sécurité sanitaire des produits de santé (2011) Vaccins pandémiques grippe A(H1N1) et narcolepsie- Actualisation des données- Communiqué. The French Mdical Agency website. Available: http://www.afssaps.fr/Infos-de-securite/Communiques-Points-presse/Vaccins-pandemiques-grippe-A-H1N1-et-narcolepsie-Actualisation-des-donnees-Communique. Accessed 2011 April 4.
37. The Norwegian Medical Agency press release (2011) Narkolepsi og Pandemrix - nye norske tall. Available: http://www.slv.no/templates/InterPage____83135.aspx. Accessed 2012 Feb 8.
38. Health Service Executive of Ireland. Statement re Narcolepsy/Pandemrix (2011) Available: http://www.hse.ie/eng/services/newscentre/newsarchive/2011archive/sept2011/NarcolepsyPandemrix.html.Accessed 2011 Nov 2.